Commence Bio's Incubator/Accelerator Round

Commence Bio raised a round of funding on January 17, 2013. Investors include JLabs.

Commence Bio is developing cellular immunotherapies for cancer, inflammatory diseases, cells, and media for veterinary medicine, research, and 3D bioprinting. …

Articles about Commence Bio's Incubator/Accelerator Round: